Related Experiment Video
Updated: Sep 30, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Identical EP300 variant leading to Rubinstein-Taybi syndrome with different clinical and immunologic phenotype
Francesco Saettini1,2, Grazia Fazio2, Maria Teresa Bonati3
1Pediatric Hematology Outpatient Clinic, Pediatric Department, Fondazione MBBM, Monza, Italy.
Abstract:
The Rubinstein-Taybi syndrome (RSTS) is a rare developmental disorder characterized by craniofacial dysmorphisms, broad thumbs and toes, intellectual disability, growth deficiency, and recurrent infections. Mutations in the cyclic adenosine monophosphate response element-binding protein (CREB)-binding protein (CREBBP) or in the E1A-associated protein p300 (EP300) genes have been demonstrated in 55% (RSTS1) and up to 8% of the patients (RSTS2), respectively. Dysfunction of immune response has been reported in a subgroup of individuals with RSTS. Here we characterize two patients carrying the same EP300 variant and distinctive RSTS features (including congenital heart abnormalities, short stature, feeding problems, and gastroesophageal reflux). Whole exome sequencing did not support a dual molecular diagnosis hypothesis. Nonetheless, patients showed distinct clinical manifestations and immunological features. The most severe phenotype was associated with reduced T-cell production and diversity. This latter feature was confirmed in a control group of four RSTS patients.
Related Concept Videos
Epistasis
Epistasis Analysis
Pleiotropy
Cross-reactivity
Incomplete Dominance

